Paper35669482
Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis.
Chen X and 11 others. Front Cardiovasc Med, 2022. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis. Papers, record 35669482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35669482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31988143 | Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors. | J Immunother Cancer | 2020 | https://conductscience.org/library/papers/31988143 | PubMed |
| 2 | 25705383 | Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome. | J Immunother Cancer | 2015 | https://conductscience.org/library/papers/25705383 | PubMed |
| 3 | 30453170 | Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors. | Eur J Cancer | 2019 | https://conductscience.org/library/papers/30453170 | PubMed |
| 4 | 25901283 | Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma. | J Immunother Cancer | 2015 | https://conductscience.org/library/papers/25901283 | PubMed |
| 5 | 29802219 | Immune Checkpoint Inhibitor-Associated Myocarditis. | Oncologist | 2018 | https://conductscience.org/library/papers/29802219 | PubMed |
| 6 | 27806233 | Fulminant Myocarditis with Combination Immune Checkpoint Blockade. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27806233 | PubMed |
| 7 | 30993259 | Managing cardiotoxicity associated with immune checkpoint inhibitors. | Chronic Dis Transl Med | 2019 | https://conductscience.org/library/papers/30993259 | PubMed |
| 8 | 30242316 | Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/30242316 | PubMed |
| 9 | 30589930 | Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/30589930 | PubMed |
| 10 | 29158217 | Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity. | Circulation | 2017 | https://conductscience.org/library/papers/29158217 | PubMed |
| 11 | 11298087 | T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective. | Clin Endocrinol (Oxf) | 2001 | https://conductscience.org/library/papers/11298087 | PubMed |
| 12 | 31169866 | Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/31169866 | PubMed |
| 13 | 29209563 | Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/29209563 | PubMed |
| 14 | 31390169 | Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology | Circulation | 2019 | https://conductscience.org/library/papers/31390169 | PubMed |
| 15 | 29536852 | Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis. | Lancet | 2018 | https://conductscience.org/library/papers/29536852 | PubMed |
| 16 | 29567210 | Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/29567210 | PubMed |
| 17 | 34030688 | Effects of diabetes on the development of radiation pneumonitis. | Respir Res | 2021 | https://conductscience.org/library/papers/34030688 | PubMed |
| 18 | 29379889 | A unique reason for coronary spasm causing temporary ST elevation myocardial infarction (inferior STEMI) - systemic inflammatory response syndrome after use of pembrolizumab. | Arch Med Sci Atheroscler Dis | 2017 | https://conductscience.org/library/papers/29379889 | PubMed |
| 19 | 34607896 | Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/34607896 | PubMed |
| 20 | 33714688 | Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines. | Trends Immunol | 2021 | https://conductscience.org/library/papers/33714688 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41859044 | Preliminary exploration of the role of CD8+ T cells in anti-PD-1 antibody-induced myocarditis in C57BL/6 mice with Lewis lung carcinoma. | Biomed Rep | 2026 | https://conductscience.org/library/papers/41859044 | PubMed |
| 41710664 | Case Report: Immunotherapy-induced myocarditis requiring pacemaker insertion in an older adult. what happens if we rechallenge? | Front Oncol | 2026 | https://conductscience.org/library/papers/41710664 | PubMed |
| 41680658 | Nomogram-based prediction of checkpoint inhibitor pneumonitis in lung cancer patients. | BMC Cancer | 2026 | https://conductscience.org/library/papers/41680658 | PubMed |
| 41647338 | Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: multicenter study using natural language processing on Belgian hospital data. | ESMO Real World Data Digit Oncol | 2025 | https://conductscience.org/library/papers/41647338 | PubMed |
| 40940933 | Immunotherapy-Associated Cardiotoxicity: Current Insights and Future Directions for Precision Cardio-Oncology. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40940933 | PubMed |
| 40851558 | Hemoglobin is associated with cardiotoxicity in melanoma patients without anemia receiving immune checkpoint inhibitor therapy. | Int J Cardiol Heart Vasc | 2025 | https://conductscience.org/library/papers/40851558 | PubMed |
| 40821806 | The impact of immune checkpoint inhibition on atherosclerosis in cancer patients. | Front Immunol | 2025 | https://conductscience.org/library/papers/40821806 | PubMed |
| 40741581 | Cardiovascular Toxicity Associated With Immune Checkpoint Inhibitors: Interpreting the Discrepancy Between Clinical Trials and Real-World Data. | Cureus | 2025 | https://conductscience.org/library/papers/40741581 | PubMed |
| 40704609 | Risk factors of immune checkpoint inhibitor-related cardiotoxicity: a scoping review. | Oncologist | 2025 | https://conductscience.org/library/papers/40704609 | PubMed |
| 40411721 | Unmasking the Rare but Lethal Cardiac Complications of Immune Checkpoint Inhibitor Therapy: A Review of Mechanisms, Risk Factors, and Management Strategies. | Curr Treat Options Oncol | 2025 | https://conductscience.org/library/papers/40411721 | PubMed |
| 39982537 | Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis. | Cancer Metastasis Rev | 2025 | https://conductscience.org/library/papers/39982537 | PubMed |
| 39981496 | Predictive Value of Neutrophil-to-Lymphocyte Ratio for Immune Checkpoint Inhibitor-Related Myocarditis Among Patients Treated for Non-Small-Cell Lung Cancer. | Cancer Innov | 2025 | https://conductscience.org/library/papers/39981496 | PubMed |
| 39949762 | Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis. | Front Immunol | 2025 | https://conductscience.org/library/papers/39949762 | PubMed |
| 39738878 | The role of tumor types in immune-related adverse events. | Clin Transl Oncol | 2025 | https://conductscience.org/library/papers/39738878 | PubMed |
| 39286288 | Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/39286288 | PubMed |
| 39082198 | Early identification of severe immune checkpoint inhibitor associated myocarditis: From an electrocardiographic perspective. | Cancer Med | 2024 | https://conductscience.org/library/papers/39082198 | PubMed |
| 38137806 | Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge. | J Clin Med | 2023 | https://conductscience.org/library/papers/38137806 | PubMed |
| 37955712 | High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapy. | Clin Res Cardiol | 2024 | https://conductscience.org/library/papers/37955712 | PubMed |
| 37902905 | Clinical characteristics and prognostic impact of immune checkpoint inhibitor-associated myocarditis in advanced non-small cell lung cancer. | Invest New Drugs | 2023 | https://conductscience.org/library/papers/37902905 | PubMed |
| 37711551 | Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma-a review and prospects for the future. | Front Cardiovasc Med | 2023 | https://conductscience.org/library/papers/37711551 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CMPK1 | 51727 | PubTator's text mining | https://conductscience.org/library/genes/51727 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| IL13 | 3596 | PubTator's text mining | https://conductscience.org/library/genes/3596 | NCBI Gene |
| IL4 | 3565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| IL5 | 3567 | PubTator's text mining | https://conductscience.org/library/genes/3567 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35669482
GET https://conductscience.org/api/papers/v1/35669482/references?page=2